Cocktail Reception
Welcome & Networking
Registration

Breakfast

Session 1: Pathogen and host biology (I)

9:00   *Douglas Young, Imperial College London
The diversity of latent TB

9:30    Markus Wenk, National University of Singapore
Lipidomics in biomarker development

10:00 am - 10:30 am            Coffee Break

10:30   Sebastien Gagneux, MRC National Institute for Medical Research
Evolutionary forces in Mycobacterium tuberculosis: Implications for product development

11:00   JohnJoe McFadden, University of Surrey
Systems approaches to uncovering in vivo state of the TB bacillus

Session 2: Pathogen and host biology (II)

1:30     *Stefan Kaufmann, Max Planck Institute for Infection Biology
Host response to tuberculosis as basis for rational design of vaccines and biomarkers

2:00     T. Mark Doherty, Statens Serum Institut
Separating latent and acute TB

2:30     Padmini Salgame, University of Medicine and Dentistry of New Jersey
Probing the mechanisms that regulate mycobacterial Th1 immunity

3:00 pm - 3:30 pm            Coffee break 

3:30     Marila Gennaro, Public Health Research Institute, University of Medicine and Dentistry of New Jersey
Genome-scale antibody responses in TB

Poster Session

5:00 pm - 5:45 pm       Late Breakers

Joshua Mattila
Early immunologic events in cynomolgus macaques coinfected with Mycobacterium tuberculosis and a pathogenic siman immunodeficiency virus

Melissa Nyendak
The diagnostic potential of the CD8+ T cell response: tracking intracellular infection with Mycobacterium tuberculosis

Hugh Salamon
Statistical pathway analysis of antibody responses to the Mycobacterium tuberculosis proteome reveals molecular features of active infection in patients

Martin Vordermeier
Using murine global gene expression analysis to predict biomarkers of protective immunity in cattle: A role for IL-17 producing cells in protective immunity?

Session 3: The child's immune system and pediatric tuberculosis

9:00     Joe Bellanti, Georgetown University Medical Center
The child's immune system and pediatric tuberculosis

Session 4: Field studies and clinical trials: present and future

10:30   *Dick Menzies, McGill University
Evaluating new diagnostic tests in the field – are we doing it right?

11:00   Sandra Arend, Leiden University Medical Center
A specific skin test; the best for both worlds?

Session 5:New strategies for immunodiagnosis (I)

1:30     Mark Perkins, Foundation for New and Innovative Diagnostics TB immunodiagnosis in context of global disease care and control

Session 6: New strategies for Immunodiagnosis (II)

3:00     *Mario Roederer, National Institute of Allergy and Infectious Diseases
Multifunctional Analysis of Antigen-Specific T Cells: Correlates of Vaccine Efficacy

3:30     Abraham Lee, University of California, Irvine
Novel microfluidic technologies for portable diagnostics systems

Poster Session

4:45 pm - 5:30pm            Late Breakers

Pernille Ravn
Improving blood based assays for the diagnosis of active and latent TB infection using IP10; Preliminary data from HIV positive TB patients and children with LTBI

Beate Kampmann
Immune responses to mycobacteria in immunocompetent and immunocompromised children

Françoise Mascart
HBHA-induced interferon-gamma release assay for the diagnosis of both latent and active tuberculosis

Karen Steingart and Suman Laal
Serodiagnosis of TB: 1. A meta-analysis of the performance of purified antigens of M. tuberculosis and 2. Synthetic peptides of new specific cell-wall proteins for TB diagnosis